Our Latest
November 18, 2026Press releaseNovember 18, 2026
Zebrafish Service Market Outlook 2026-2032: AI-Powered Imaging, Genome Editing, and Drug Screening Propel 8.84% CAGR to $228.56 Million
B
BiotechNews.io6 min read
Press releaseNovember 18, 2026
Quantum-Si Achieves Historic Milestone in Protein Sequencing with Single-Molecule Detection of All 20 Amino Acids on Proteus™
B
BiotechNews.io6 min read
Press releaseNovember 18, 2026
BillionToOne to Participate in the Piper Sandler 38th Annual Healthcare Conference
B
BiotechNews.io1 min read
Also on the bench
- Optimi Health Outlines 2027 Plans for OPTI-101 Phase 2b in Major Depressive Disorder and OPTI-201 Phase 3 in PTSD; Announces Shares-for-Debt Settlement
- Mass photometry reaches 2,000-publication milestone as applications expand
- Olema Oncology Presents Preclinical Data on Selective KAT6A Degraders in ER+/HER2- Breast Cancer Models at EORTC-NCI-AACR Symposium
- Elutia Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
- PacBio to Participate in the Piper Sandler 38th Annual Healthcare Conference
- Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
- CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Global DNA Polymerase Market Report - 2026 Edition: Size, Share, Growth and Forecast to 2030 | Market to Reach US$2.85B as Genomics, Diagnostics and Synthetic Biology Accelerate
- Rat Models - Global Strategic Business Report 2026: Secure Share of a $2.9 Billion Market by 2032
- Veru Presents New Results at ObesityWeek 2026: GLP-1 Weight Loss in Older Adults Associated with Physical Function Decline; Adding Enobosarm Preserved Significant Lean Mass and Physical Function
- Nexentis: MitoCareX Progresses Toward In-Vitro Evaluation Following AI-Powered Computational Screening
- Insight Molecular Diagnostics Announces Pricing of $15 Million Public Offering
- BetterLife Pharma Announces Stock Option Grant
- BetterLife Pharma Announces New Preclinical Research Highlighting Neuroplasticity-Related Effects of Non-Hallucinogenic BETR-001 at Neuroscience 2026
- Senti Bio Announces Reverse Stock Split
- Thermosome Closes Exclusive Global Licensing Agreement with Avenor Therapeutics
- Mobile Apps for DNA Sequencing Market to Reach $2.4 Billion by 2031
- Kraig Biocraft Laboratories CEO Publishes Forbes Technology Council Article on the Future of Bio-Engineered Materials
- Zenas BioPharma Launches The Distance Between Platform to Bring Greater Visibility to the Hidden Burden of IgG4-Related Disease
View all Posts124 posts on Biotech News